Cagrilintide 5mg

Description

Cagrilintide 5mg – Long-Acting Amylin Analog Peptide

Contents: Cagrilintide 5mg Lyophilized Peptide
Category: Amylin Receptor Agonist / Research Peptide
Administration: For laboratory and research use only

Cagrilintide is a long-acting synthetic analog of amylin, a hormone involved in appetite regulation and post-meal satiety signaling. It is widely studied in metabolic research for its role in reducing food intake and supporting energy balance through central and peripheral pathways.

Due to its prolonged activity and strong satiety-related signaling, Cagrilintide is often investigated in combination with other metabolic compounds in obesity and weight-management research models.

Key Features

• Long-acting amylin receptor agonist
• Studied for appetite and satiety regulation pathways
• Supports energy balance and metabolic research
• Investigated in body weight management models
• Often studied in combination metabolic protocols
• High-purity lyophilized research compound

How It Works

Cagrilintide mimics the action of amylin, a hormone co-secreted with insulin, influencing appetite and postprandial responses.

Satiety Signaling

• Enhances feelings of fullness
• Reduces food intake in research models
• Supports appetite regulation pathways

Metabolic Regulation

• Influences energy intake and balance
• Studied in weight-management research
• Supports glucose-related satiety signaling

Research Applications

• Used in metabolic and obesity models
• Often combined with GLP-1 pathway compounds
• Investigated in long-acting peptide studies

Why Choose Cagrilintide?

Cagrilintide is a next-generation amylin analog studied for its strong and sustained effects on satiety signaling and energy balance, making it a valuable compound in metabolic and weight-management research.

Important Notice

This product is intended strictly for laboratory, educational, and research use only. Not for human consumption or therapeutic use. Proper laboratory handling and safety procedures are required.